Cerebral amyloid angiopathy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Cerebral amyloid angiopathy
Micrograph of cerebral amyloid angiopathy
Synonyms	CAA
Pronounce	N/A
Specialty	N/A
Symptoms	Headache, seizures, stroke, dementia
Complications	Intracerebral hemorrhage, cognitive impairment
Onset	Typically in older adults
Duration	Chronic
Types	N/A
Causes	Deposition of amyloid beta in the walls of the blood vessels of the central nervous system
Risks	Age, genetic factors, hypertension
Diagnosis	MRI, CT scan, biopsy
Differential diagnosis	Alzheimer's disease, vascular dementia, primary angiitis of the central nervous system
Prevention	N/A
Treatment	Supportive care, antihypertensive therapy, anticoagulation (with caution)
Medication	N/A
Prognosis	Variable, depends on severity and complications
Frequency	Common in the elderly
Deaths	N/A

Astrocyte

File:Compare SWI and GRE CAA.png

Comparison of SWI and GRE in cerebral amyloid angiopathy

Cerebral amyloid angiopathy (CAA) is a neurological condition characterized by the accumulation of amyloid proteins in the walls of the blood vessels in the brain. This condition is often associated with Alzheimer's disease and other neurodegenerative disorders.

Etiology

The exact cause of CAA is unknown. However, it is believed to be related to the abnormal processing of amyloid precursor protein (APP), which leads to the accumulation of amyloid proteins in the brain's blood vessels. This process is similar to the one observed in Alzheimer's disease, where amyloid plaques accumulate in the brain tissue.

Pathophysiology

In CAA, amyloid proteins accumulate in the walls of the small to medium-sized blood vessels in the brain, leading to vessel wall thickening and reduced blood flow. This can result in microbleeds, microinfarcts, and, in severe cases, intracerebral hemorrhage. The most commonly involved protein is amyloid beta, the same protein involved in the formation of amyloid plaques in Alzheimer's disease.

Clinical Presentation

The clinical presentation of CAA can vary widely. Some individuals may remain asymptomatic, while others may present with cognitive impairment, dementia, stroke, or intracerebral hemorrhage. The risk of developing symptoms increases with age.

Diagnosis

Diagnosis of CAA is often challenging due to its nonspecific symptoms and the lack of definitive diagnostic tests. It is often diagnosed based on clinical presentation, neuroimaging findings, and, in some cases, brain biopsy. The Boston criteria is commonly used to diagnose CAA.

Treatment

There is currently no cure for CAA. Treatment is primarily focused on managing symptoms and preventing complications, such as stroke and intracerebral hemorrhage. This may involve the use of antihypertensive medications, anticoagulants, and statins.

Prognosis

The prognosis of CAA varies depending on the severity of the condition and the presence of complications. In severe cases, CAA can lead to significant disability and death.

See Also

• Alzheimer's disease
• Amyloidosis
• Stroke
• Intracerebral hemorrhage